A case of relapsing and refractory catastrophic anti-phospholipid syndrome successfully managed with eculizumab, a complement 5 inhibitor.

Surabhi Wig, Marian Chan, Jecko Thachil, Ian Bruce, Theresa Barnes

    Research output: Contribution to journalArticlepeer-review

    Original languageEnglish
    JournalRheumatology (Oxford, England)
    Volume55
    Issue number2
    DOIs
    Publication statusPublished - Feb 2016

    Cite this